Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux (Q28267787)

0 references

Robert S Kiss

0 references

Lea Sarov-Blat

0 references

Roch Brunet

0 references

Christopher Harder

0 references

Ruth McPherson

0 references

Yves L Marcel

Journal of Biological Chemistry

0 references

language of work or name

English

0 references

publication date

29 December 2006

0 references

published in

0 references

volume

281

0 references

issue

0 references

page(s)

39971-81

0 references

cites work

Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Endosomal-lysosomal proteolysis mediates death signalling by TNFalpha, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cathepsin D targeted by acid sphingomyelinase-derived ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Autocatalytic proteolysis of the zymogen form of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Glucosylceramide modulates membrane traffic along the endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cellular localization and trafficking of the human ABCA1 transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

The lipoprotein receptor-related protein-1 (LRP) adapter protein GULP mediates trafficking of the LRP ligand prosaposin, leading to sphingolipid and free cholesterol accumulation in late endosomes and impaired efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Biosynthesis and degradation of mammalian glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Saposin B binds and transfers phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Topology of glycosphingolipid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Lipid abnormalities in children with types A and B Niemann Pick disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cathepsins as transcriptional activators?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Molecular organization of the human cathepsin D gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Characterization of the proximal estrogen-responsive element of human cathepsin D gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Retinoid regulation of human cathepsin D gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200

Direct evidence of importance of lysosomes in degradation of intracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605095200